CORE--PROTOCOL SPECIFIC RESEARCH

UPCI临床试验工作的主要目标是设计、实施和分析创新的， 药物启动的I期和II期临床试验。制定、发起、执行和 UPCI临床研究的完成得到了UPCI临床研究服务（CRS）的实质性和必要的支持。指定的临床研究协调员参与研究设计和实施、研究方案设计、表格设计、患者教育和依从性、标本采集、处理和运输、数据采集和录入，并将所有患者和研究问题告知主要研究者。 UPCI在过去5年中在创新试点和I期研究方面取得了显著进展，包括分子治疗和药物发现，生物治疗，前列腺和泌尿系统癌症，头颈癌，免疫学和乳腺癌。PSRC由来自所有这些和其他计划的UPCI成员使用。

A primary goal of the clinical trials efforts of UPCI is to design, implement and analyze innovative, investigator-initiated phase I and II clinical trials. The dcvelopment, initiation, implementation and completion of UPCI investigational studies receive substantial and essential support from UPCI Clinical Research Services (CRS). The assigned clinical research coordinators are involved in study design and implementation, design of study schema, forms design, patient education and compliance, collection, handling and shipping of specimens, collection and entry of data and keeping the principal investigator informed of all patient and research issues. UPCI has made noteworthy advances, in innovative pilot and phase I studies in the last 5 years, in several programs including Molecular Therapeutics and Drug Discovery, Biological Therapeutics, Prostate and Urologic Cancers, Head and Neck Cancer, Immunology, and breast cancer. The PSRC is utilized by UPCI members from all of these and other programs.